P84 High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

• DOI: 10.1016/s0959-8049(97)89301-x
• Publication Date: 2003-07-09T16:14:27Z
• Authors: E. Galligioni; G. Cetto; O. Nascimben; A. Buonadonna; D. Crivellari; A. Molino; A. Veronesi; C. Graiff; S. Barni; C. Puccetti; E. Ferrazzi; E. Recaldin; C. Sava; S. Saracchini; C. Sacco
• Keywords: 03 medical and health sciences; 0302 clinical medicine